Literature DB >> 33842267

Narrative review of liver mobilization, diaphragm peritonectomy, full-thickness diaphragm resection, and reconstruction.

Wonkyo Shin1, Jaehee Mun2, Sang-Yoon Park2, Myong Cheol Lim2,3,4,5.   

Abstract

Epithelial ovarian cancer is the most lethal among gynecologic cancers. Despite advances in research efforts to cure this disease, the recurrence and survival rates have not significantly improved. Primary cytoreductive surgery and adjuvant chemotherapy are the standard treatment options for patients with epithelial ovarian cancer. Two randomized trials recently introduced neoadjuvant chemotherapy followed by interval cytoreductive surgery as an alternative treatment option. In any case, the size of the residual tumor after surgery is the most important prognostic factor for patients with ovarian cancer. With the improvement of surgical techniques in gynecologic oncology, cytoreductive surgery is now performed for the pelvic area and entire abdomen. Currently, surgical resectability of a mass spreading into the upper abdomen is the most important factor for achieving optimal cytoreduction. In this study, we explain the procedure of a cytoreductive surgery, involving the resection of a tumor located in the upper abdomen. We aimed to review and describe the surgical techniques involved in liver mobilization, diaphragm peritonectomy, and full-thickness diaphragm resection and reconstruction. Further, we have assessed the postoperative care involved and discussed complications that may possibly arise along with suggestions to avoid them based on the review of previous literature on the subject. 2021 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Ovarian cancer (OC); cytoreductive surgery; diaphragm; residual tumor

Year:  2021        PMID: 33842267      PMCID: PMC8033081          DOI: 10.21037/gs-20-422

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  30 in total

1.  Resection of a metastatic bulky subphrenic tumor for the treatment of advanced ovarian cancer using liver mobilization and the Pringle maneuver.

Authors:  Kyoko Nishikimi; Shinichi Tate; Ayumu Matsuoka; Makio Shozu
Journal:  Gynecol Oncol       Date:  2018-08-20       Impact factor: 5.482

2.  Diaphragmatic peritonectomy vs. full thickness resection with pleurectomy during Visceral-Peritoneal Debulking (VPD) in 100 consecutive patients with stage IIIC-IV ovarian cancer: A surgical-histological analysis.

Authors:  Hooman Soleymani Majd; Federico Ferrari; Sanjiv Manek; Kumar Gubbala; Riccardo Garruto Campanile; Kieran Hardern; Roberto Tozzi
Journal:  Gynecol Oncol       Date:  2015-12-12       Impact factor: 5.482

3.  The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.

Authors:  Oliver Zivanovic; Eric L Eisenhauer; Qin Zhou; Alexia Iasonos; Paul Sabbatini; Yukio Sonoda; Nadeem R Abu-Rustum; Richard R Barakat; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2007-11-13       Impact factor: 5.482

Review 4.  Dissemination of intraperitoneal ovarian cancer: Discussion of mechanisms and demonstration of lymphatic spreading in ovarian cancer model.

Authors:  Anis Feki; Philip Berardi; Geoff Bellingan; Attila Major; Karl-Heinz Krause; Patrick Petignat; Rubab Zehra; Shazib Pervaiz; Irmgard Irminger-Finger
Journal:  Crit Rev Oncol Hematol       Date:  2009-10       Impact factor: 6.312

5.  Diaphragm resection for ovarian cancer: technique and short-term complications.

Authors:  William Cliby; Sean Dowdy; Simone S Feitoza; Bobbie S Gostout; Karl C Podratz
Journal:  Gynecol Oncol       Date:  2004-09       Impact factor: 5.482

Review 6.  Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.

Authors:  Tsz-Lun Yeung; Cecilia S Leung; Kay-Pong Yip; Chi Lam Au Yeung; Stephen T C Wong; Samuel C Mok
Journal:  Am J Physiol Cell Physiol       Date:  2015-07-29       Impact factor: 4.249

7.  Extended left upper quadrant resection during primary cytoreductive surgery for Stage IV ovarian cancer.

Authors:  Brandon T Sawyer; Christopher J LaFargue; Robert E Bristow
Journal:  Gynecol Oncol       Date:  2016-06-06       Impact factor: 5.482

8.  Intraperitoneal disease dissemination patterns are associated with residual disease, extent of surgery, and molecular subtypes in advanced ovarian cancer.

Authors:  Diogo Torres; Amanika Kumar; Sumer K Wallace; Jamie N Bakkum-Gamez; Gottfried E Konecny; Amy L Weaver; Michaela E McGree; Ellen L Goode; William A Cliby; Chen Wang
Journal:  Gynecol Oncol       Date:  2017-09-28       Impact factor: 5.482

9.  Diaphragmatic peritonectomy versus full thickness diaphragmatic resection and pleurectomy during cytoreduction in patients with ovarian cancer.

Authors:  P N J Pathiraja; R Garruto-Campanile; R Tozzi
Journal:  Int J Surg Oncol       Date:  2013-12-18

10.  Diaphragmatic Surgery and Related Complications In Primary Cytoreduction for Advanced Ovarian, Tubal, and Peritoneal Carcinoma.

Authors:  Shuang Ye; Tiancong He; Shanhui Liang; Xiaojun Chen; Xiaohua Wu; Huijuan Yang; Libing Xiang
Journal:  BMC Cancer       Date:  2017-05-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.